Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18] RGD-K5 PET in Carotid Artery Stenosis
NCT01968226Phase 2Terminated
- Sponsor
- Cleveland Clinic
- Start
- Nov 2013
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of flotegatide in carotid artery disease, carotid artery stenosis, sponsored by Cleveland Clinic. Started Nov 2013; status: terminated.
02
Drugs
flotegatide
03
Conditions
carotid artery diseasecarotid artery stenosis
Beyond the preview
Go deeper on NCT01968226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968226.